Adaptation of Elecsys anti-severe acute respiratory syndrome coronavirus-2 immunoassay to dried blood spots: proof of concept

Aim: Several automated immunoassays have been validated on serum/plasma to evaluate the presence of significant levels of anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) antibodies, signs of a present or past infection, but the use of dried blood spots (DBS) would facilitate sampling, shipping and storage.

Read the article.


Skills

Posted on

March 17, 2021